SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-005487
Filing Date
2021-02-19
Accepted
2021-02-19 16:05:43
Documents
13
Period of Report
2021-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10020219x2_8k.htm   iXBRL 8-K 21179
  Complete submission text file 0001140361-21-005487.txt   204369

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bngo-20210215.xsd EX-101.SCH 4886
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20210215_def.xml EX-101.DEF 18271
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20210215_lab.xml EX-101.LAB 28167
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20210215_pre.xml EX-101.PRE 20514
6 EXTRACTED XBRL INSTANCE DOCUMENT nt10020219x2_8k_htm.xml XML 6491
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 21655591
SIC: 3826 Laboratory Analytical Instruments